Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Opdivo Granted Priority Review for Post-Surgical Melanoma Treatment

October 18th 2017

Opdivo (nivolumab) was granted a priority review to a supplemental biologics license application (sBLA) to treat patients with melanoma who have a high risk of disease recurrence after complete surgical resection, according to Bristol-Myers Squibb (BMS), the company that makes the drug.

Stubbornness Will Get You Through Cancer

October 12th 2017

Seven-year cancer survivor shares tips to help you get through cancer.

Challenges Remain in Melanoma Treatment, Expert Says

October 8th 2017

Merrick I. Ross, M.D., discussed key issues in melanoma as the treatment paradigm continues to change.

Moving Forward Through Fear of Recurrence

October 5th 2017

Breast cancer survivor shares how she copes with fear of recurrence while coping with her mom's breast cancer death and other life changes.

Pen-Like Device May Help Detect Melanoma

October 5th 2017

Patients and providers can evaluate lesions within seconds by running the tip of the device over their skin, and then link the results to a user-friendly smartphone app.

Drug Pair Benefits Patients With Melanoma Who Progressed on Prior Therapy

October 3rd 2017

Combination therapy of Opdivo (nivolumab) and LAG-3 inhibitor relatlimab (BMS-986016) benefitted half of the patients with melanoma who previously progressed on an anti-PD-1 or anti-PD-L1 therapy, according to recent results from a dose-expansion study.

When to Stop Immunotherapy Treatment for Melanoma

October 2nd 2017

Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.

Would Recent Advancements Make You Revisit Cancer?

September 27th 2017

Would you go see a genetics counselor again, now that there may be more to test for? Would you get a double mastectomy seven years out?

5 Health Care Wishes from a Cancer Survivor

September 25th 2017

Breast cancer survivor reflects back on what she wishes the medical profession's approach could have been to her cancers.

On Cancer and Facing Death Bravely

September 22nd 2017

Two-time cancer survivor says lets look death and dying in the face so we don't live our lives in (as much) fear.

White Blood Cell Ratios Predict Melanoma Patients' Survival

September 21st 2017

The ratio of neutrophils to lymphocytes – two types of white blood cells – can give oncologists valuable information regarding a patient’s prognosis.

Drug Combination Improves Outcomes for Melanoma Subtype

September 20th 2017

In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present – with neoadjuvant combination therapy consisting of Tafinlar (dabrafenib) and Mekinist (trametinib).

Expert Urges Patients to Speak Up About Treatment Side Effects

September 19th 2017

Jeffrey Weber, M.D., Ph.D., Deputy Director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses how important it is that patients speak up when they experience side effects from their cancer treatments.

When Cancer's Side Effects Return

September 15th 2017

An injured cancer survivor reluctantly but gratefully copes with neuropathy, osteopenia and stiff-joint cancer side effects after recently breaking her foot and getting surgery.

Combination Therapy Could Revolutionize Melanoma Treatment

September 13th 2017

The risk of relapse dropped 53 percent when trametinib and dabrafenib were used after therapy.

Cancer and Coping With Unrelated Medical Worry

September 8th 2017

Be prepared. After cancer, other medical issues can trigger outsized emotional responses.

New Drug on the Fast Track for Melanoma Treatment

September 5th 2017

A new drug may be on the way to treat patients with advanced melanoma, as the FDA granted LN-144, which is produced by Iovance Biotherapeutics, a fast track designation. The drug uses tumor-infiltrating lymphocyte (TIL) technology to bolster the body’s immune system to attack cancer cells.

Oh, the Places You Won't Go: Being Grounded by Cancer

September 5th 2017

A cancer diagnosis robs us of many things. For an avid traveler, its like a bird being trapped in a cage.

Fall Clutter Clearing: Weed Out Cancer Supplies After Active Treatment

September 5th 2017

A breast cancer and melanoma survivor who also speaks and writes about clutter clearing shares some cancer clutter clearing tips.

The Last Weekend of Summer as a Melanoma Survivor

August 31st 2017

Melanoma survivor offers help based on her own melanoma experience and reading.

Cancer Anxiety? Survivor Says Talk to a Therapist

August 31st 2017

Survivor shares that there is no shame to talk to a therapist about life’s difficulties, especially when those difficulties have included coping with a cancer diagnosis and the ongoing fear of recurrence.

Cancer With Benefits: What A Survivor Hopes She Has Learned

August 30th 2017

Cancer has a silver lining, too. Breast cancer and melanoma survivor shares hers.

Tips From a Cancer Fatigue Survivor

August 22nd 2017

Two-time cancer survivor offers help for fatigue, including fatigue that is months and years out from active treatment

Reflections From A Survivor Lucky Enough To Be There

August 15th 2017

Breast cancer and melanoma survivor comments on downsizing from a cancer survivor's perspective.

The Other Side of The Phone Call

August 3rd 2017

Breast cancer survivor approaches the phone with dread with Mom in hospice with breast cancer.

FDA Approves Yervoy for Pediatric Melanoma Population

July 24th 2017

Yervoy (ipilimumab) was granted approval by the Food and Drug Administration (FDA) for the treatment of pediatric patients who are 12 years old or younger and have unresectable or metastatic melanoma, according to Bristol-Myers Squibb (BMS), the manufacturer of the CTLA-4 inhibitor.

A Team Effort to Fight Melanoma

July 19th 2017

Diagnosed with desmoplastic melanoma, sportscaster Holly Rowe is working with the Melanoma Research Foundation to teach about the disease.

Immunotherapy Moves Into Rare Skin Cancer Type

July 17th 2017

An immunotherapy has become the first of its kind approved to treat Merkel cell carcinoma, a rare and still mysterious skin cancer.

When Treating Your Skin Cancer, Protect Your Pets

July 14th 2017

Creams containing the chemotherapy 5-fluorouracil can be fatal to animals, the FDA warns.

Individualized Therapy Improves Cancer Outcomes

July 13th 2017

In treating rare advanced skin cancers, individualized therapy is improving outcomes.